analySEEs
2008
M a r k e t i n g P l a n
Ciprofloxacin
www.analySEEs.co.uk
www.analySEEs.co.uk
1 . 0 M a r k e t S u m m a r y
Ciprofloxacin is an antibiotic of Fluoroquinolones group. Ciprofloxacin is the fifth
largest generic in the total Pharma market. At the same time this market is
continuously growing. Almost all leading companies paid their deep concentration
in this market and this generic market has become more competitive. The leading
brand Ciprocin (SQA) enjoys 20% share of Ciprofloxacin market. On the other hand
the second brand leader Neofloxin continuously is loosing its market share. For that
reason they reduced the price of all strength of Neofloxin. After that almost all
leading brands including Ciprocin have become available at reduced price.
Introduction of powder for suspension form add new cherry to the Ciprofloxacin
market. Consecutive introduction of Ciprofloxacin suspension by seven company
and price reduction issue make a noise in Ciprofloxacin market. So to compete in
the competition and to increase market share we are proposing two campaigns
named “Ciprofloxacin Patron” and “Ciprofloxacin Idol”.
Therapeutic Class/
Sub-class
2008
2007
2006
Val*
Sh% Gr.% Val*
Sh% Gr.% Val*
Sh% Gr.%
Cephalosporins & Combs
3081
46
10
2802
43
9
2583
41
8
Fluoroquinolones
1651
24
4
1583
24
6
1489
24
14
Penicillins
1105
16
-12
1260
19
-6
1335
21
-4
Macrolides & Similar Types
566
8
12
504
8
6
474
7
9
Trimethoprim Combs
160
2
-21
203
3
-11
229
4
-21
Tetracyclines & Combs
143
2
-16
170
3
-7
183
3
-7
Aminoglycosides
18
1
-3
19
0
-16
22
0
8
Chloramphenicols &
Combs
9
0
-28
13
0
-11
14
0
-21
Other Antibiotics
11
0
-9
12
0
82
7
0
1
Source: IMS 2nd Q, 2008; Value in BDT million
OVERVIEW OF THERAPEUTIC MARKET
www.analySEEs.co.uk
Source: IMS 2nd Q, 2008